Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J S Carter

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Diabetes Care|July 1, 1996
Rapid HbA1c testing in a community settingJ S Carter, C A Houston, S S Gilliland, et al.
Diabetes Care|May 20, 1998
Adaptation of the Dartmouth COOP Charts for use among American Indian people with diabetesS S Gilliland, A J Willmer, R McCalman, et al.
The Diabetes Educator|March 1, 1997
Native American Diabetes Project: designing culturally relevant education materialsJ S Carter, S S Gilliland, G E Perez, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 1999
Synthesis and activity of sulfonamide-substituted 4,5-diaryl thiazoles as selective cyclooxygenase-2 inhibitorsJ S Carter, S Kramer, J J Talley, et al.
Ethnicity & Disease|June 4, 1999
Knowledge, attitudes and behaviors related to physical activity among Native Americans with diabetesL M Stolarczyk, S S Gilliland, D J Lium, et al.
Journal of Medicinal Chemistry|May 5, 2000
N-[[(5-methyl-3-phenylisoxazol-4-yl)-phenyl]sulfonyl]propanamide, sodium salt, parecoxib sodium: A potent and selective inhibitor of COX-2 for parenteral administrationJ J Talley, S R Bertenshaw, D L Brown, et al.
Medicinal Research Reviews|May 8, 1999
4,5-Diaryloxazole inhibitors of cyclooxygenase-2 (COX-2)J J Talley, S R Bertenshaw, D L Brown, et al.
Journal of Medicinal Chemistry|March 15, 2000
4-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, valdecoxib: a potent and selective inhibitor of COX-2J J Talley, D L Brown, J S Carter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2016
A phase I trial of paclitaxel, cisplatin, and veliparib in the treatment of persistent or recurrent carcinoma of the cervix: an NRG Oncology Study (NCT#01281852)P H Thaker, R Salani, W E Brady, et al.
Journal of Medicinal Chemistry|April 25, 1997
Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib)T D Penning, J J Talley, S R Bertenshaw, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Diabetes Care|July 1, 1996
Rapid HbA1c testing in a community settingJ S Carter, C A Houston, S S Gilliland, et al.
Diabetes Care|May 20, 1998
Adaptation of the Dartmouth COOP Charts for use among American Indian people with diabetesS S Gilliland, A J Willmer, R McCalman, et al.
The Diabetes Educator|March 1, 1997
Native American Diabetes Project: designing culturally relevant education materialsJ S Carter, S S Gilliland, G E Perez, et al.
Bioorganic & Medicinal Chemistry Letters|May 18, 1999
Synthesis and activity of sulfonamide-substituted 4,5-diaryl thiazoles as selective cyclooxygenase-2 inhibitorsJ S Carter, S Kramer, J J Talley, et al.
Ethnicity & Disease|June 4, 1999
Knowledge, attitudes and behaviors related to physical activity among Native Americans with diabetesL M Stolarczyk, S S Gilliland, D J Lium, et al.
Journal of Medicinal Chemistry|May 5, 2000
N-[[(5-methyl-3-phenylisoxazol-4-yl)-phenyl]sulfonyl]propanamide, sodium salt, parecoxib sodium: A potent and selective inhibitor of COX-2 for parenteral administrationJ J Talley, S R Bertenshaw, D L Brown, et al.
Medicinal Research Reviews|May 8, 1999
4,5-Diaryloxazole inhibitors of cyclooxygenase-2 (COX-2)J J Talley, S R Bertenshaw, D L Brown, et al.
Journal of Medicinal Chemistry|March 15, 2000
4-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, valdecoxib: a potent and selective inhibitor of COX-2J J Talley, D L Brown, J S Carter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2016
A phase I trial of paclitaxel, cisplatin, and veliparib in the treatment of persistent or recurrent carcinoma of the cervix: an NRG Oncology Study (NCT#01281852)P H Thaker, R Salani, W E Brady, et al.
Journal of Medicinal Chemistry|April 25, 1997
Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib)T D Penning, J J Talley, S R Bertenshaw, et al.
Pageof 3